Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A HITTMAIR

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1993
Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breastK W Schmid, I O Ellis, J M Gee, et al.
The Prostate|June 1, 1997
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1993
Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breastK W Schmid, I O Ellis, J M Gee, et al.
The Prostate|June 1, 1997
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.
Pageof 10